Skip to main content
VCbacked
Log inGet Started

Imperative Care

Campbell, United States

Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.

$100.0M raised
Mar 2026
Convertible Note
Health CareMedicalMedical Device

Top Investors

Perceptive AdvisorsCatalio Capital ManagementBain Capital Life SciencesAlly Bridge GroupElevage Medical Technologies

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Imperative Care

How much funding has Imperative Care raised?
Imperative Care has raised $100.0M in total funding. The most recent round was Convertible Note. The last funding was announced in March 2026.
Who are Imperative Care's investors?
Imperative Care's investors include Perceptive Advisors, Catalio Capital Management, Bain Capital Life Sciences, Ally Bridge Group, Elevage Medical Technologies.
Where is Imperative Care headquartered?
Imperative Care is headquartered in Campbell, United States.
What does Imperative Care do?
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
What stage is Imperative Care at?
Imperative Care is at the Convertible Note stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Imperative Care — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/imperative-care. Accessed June 16, 2026.
APA
VCBacked. (2026). Imperative Care — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/imperative-care
Wikipedia (cite web)
{{cite web |title=Imperative Care — Funding & Investors |url=https://www.vcbacked.co/company/imperative-care |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K